These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31611351)

  • 1. Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.
    Hussein M; Han ML; Zhu Y; Zhou Q; Lin YW; Hancock REW; Hoyer D; Creek DJ; Li J; Velkov T
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Description of Ivacaftor Elevating Polymyxin B Mediated Antibacterial Activity in Cystic Fibrosis
    Allobawi R; Ghelani DP; Schneider-Futschik EK
    ACS Pharmacol Transl Sci; 2020 Jun; 3(3):433-443. PubMed ID: 32566909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
    Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.
    Zhao J; Han ML; Zhu Y; Lin YW; Wang YW; Lu J; Hu Y; Tony Zhou Q; Velkov T; Li J
    Biochem Pharmacol; 2021 Feb; 184():114400. PubMed ID: 33387481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Gutu AD; Hertzog P; Purcell T; Shen HH; Moskowitz SM; Velkov T; Li J
    mSystems; 2019; 4(1):. PubMed ID: 30637340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin-rifampicin combination against Pseudomonas aeruginosa.
    Mahamad Maifiah MH; Zhu Y; Tsuji BT; Creek DJ; Velkov T; Li J
    J Biomed Sci; 2022 Oct; 29(1):89. PubMed ID: 36310165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant
    Lin YW; Han ML; Zhao J; Zhu Y; Rao G; Forrest A; Song J; Kaye KS; Hertzog P; Purcell A; Creek D; Zhou QT; Velkov T; Li J
    Front Pharmacol; 2019; 10():1146. PubMed ID: 31632279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR
    Hussein M; Han ML; Zhu Y; Schneider-Futschik EK; Hu X; Zhou QT; Lin YW; Anderson D; Creek DJ; Hoyer D; Li J; Velkov T
    Comput Struct Biotechnol J; 2018; 16():587-599. PubMed ID: 30546859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
    Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
    ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates.
    Wilhelm CM; Nunes LS; Martins AF; Barth AL
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):152-154. PubMed ID: 29891185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Strategy Targeting Polymyxin-Resistant Gram-Negative Pathogens: Polymyxin B in Combination with the Selective Serotonin Reuptake Inhibitor Sertraline.
    Hussein M; Schneider-Futschik EK; Paulin OKA; Allobawi R; Crawford S; Zhou QT; Hanif A; Baker M; Zhu Y; Li J; Velkov T
    ACS Infect Dis; 2020 Jun; 6(6):1436-1450. PubMed ID: 32427476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant
    Tran TB; Bergen PJ; Creek DJ; Velkov T; Li J
    Front Pharmacol; 2018; 9():359. PubMed ID: 29713282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae.
    Lu J; Han M; Yu HH; Bergen PJ; Liu Y; Zhao J; Wickremasinghe H; Jiang X; Hu Y; Du H; Zhu Y; Velkov T
    Microbiol Spectr; 2023 Aug; 11(4):e0085223. PubMed ID: 37432123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics reveals the mechanism of action of meropenem and amikacin combined in the treatment of
    Yang H; Huang Z; Yue J; Chen J; Yu M; Qu C
    Front Cell Infect Microbiol; 2023; 13():1327452. PubMed ID: 38116135
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Janet-Maitre M; Job V; Bour M; Robert-Genthon M; Brugière S; Triponney P; Cobessi D; Couté Y; Jeannot K; Attrée I
    mBio; 2024 Mar; 15(3):e0221123. PubMed ID: 38345374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MvfR Controls Tolerance to Polymyxin B by Regulating
    Yang F; Zhou Y; Bai Y; Pan X; Ha UH; Cheng Z; Wu W; Jin Y; Bai F
    Microbiol Spectr; 2023 Jun; 11(3):e0042623. PubMed ID: 37039709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.